Dyrenium
Active substance: triamterene
CAPSULE · TRIAMTERENE 50 mg/1
United StatesActive
Marketing holder: Advanz Pharma (US) Corp.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRIAMTERENE · 50 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2980-7ba5-9476-dd56732b4f70,01a12090-afd9-771a-b9e1-421f4f8bd445,01a12093-adc3-7bad-a81a-e261ae7d86c4,01a12098-c6b1-7e4d-b9f8-12ebf75c3382,01a12098-dd62-738f-b242-549f625cf8ed;count=9 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59212-002
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 59212-002 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59212-002 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59212-002 · Verified 2026-10-09 · open in source